While the KLAS report validated InsightRX for its leadership in precision dosing and clinical decision support today, the company is already expanding its platform to reach new drug classes and ...
PharmaJet plans to expand their needle-free injection portfolio with a suite of proprietary, needle-free, self-injector pens.
A deadly cough syrup contamination highlights India's drug safety flaws. Diethylene glycol, a toxic industrial solvent, was ...
Virginia’s bipartisan Joint Commission to Oversee Transition of the Commonwealth into a Retail Cannabis Market spent Monday ...
10hon MSN
Brain-on-a-chip technology reveals how sepsis and neurodegenerative diseases damage the brain
In lieu of animal experiments, researchers from the University of Rochester are using state-of-the-art microchips with human ...
Icotrokinra met the primary endpoint of clinical response at all three doses, with 36.5% of patients treated achieving ...
Ordinary human cells, not just neurons, respond more strongly to memory signals when they arrive in spaced bursts rather than ...
The growing demand for liquid medicines is increasingly driven by the unique needs of several distinct patient groups, improving compliance in these demographics through flexible, palatable dosing ...
11hon MSN
Polymer scaffold can self-assemble in tissue to deliver multiple vaccine components over time
Sometimes, the best way to achieve a big outcome is to start small. That principle is at the center of new work from a ...
Detailed price information for Biomea Fusion Inc (BMEA-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback